ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1475 National Cancer Institute Html en Adult Primary Liver Cancer Treatment (PDQ®)–Health Professional Version Expert-reviewed information summary about the treatment of adult primary liver cancer.
HCC tumors0.58507
Semin Liver Dis0.618193
Hepatocellular carcinoma incidence0.684284
PDQ cancer information0.577886
American Cancer Society0.586704
early hepatocellular carcinoma0.666995
primary biliary cirrhosis0.576504
chronic liver disease0.578131
unresectable hepatocellular carcinoma0.664574
blood flow0.562662
hepatocellular carcinoma0.977206
primary liver cancer0.589429
Natural history0.564684
cancer information summary0.576375
risk factors0.586296
normal liver parenchyma0.570598
liver disease0.607293
liver0.658374
virus-related hepatocellular carcinoma0.677568
western European patients0.565566
patients0.658086
HCC0.686159
advanced-stage HCC0.594418
small hepatocellular carcinoma0.692383
HCC patients0.615983
HCC worldwide0.602122
single hepatocellular carcinoma0.672174
Liver Italian Program0.573612
early HCC0.59445
entire liver0.564284
Liver Diseases0.560344
Gastroenterol Hepatol0.566445
AASLD hepatocellular carcinoma0.670773
untreated hepatocellular carcinoma0.669362
study0.562576
HCC detection0.593776
liver function0.561177
PUBMED Abstract0.598546
early-stage HCC0.580393
class A cirrhosis0.563518
arterial blood0.606167
liver transplant0.559717
cirrhosis0.620285
hepatitis b virus0.59513
Abstract0.629123
cirrhosis type B.0.576124
Llovet JM0.573361
cm hepatocellular carcinoma0.677106
liver resection0.566362
CLICK HERE
1552 National Cancer Institute Html en Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version Childhood ALL is a type of cancer in which the bone marrow makes too many immature lymphocytes (a type of white blood cell). Here’s what you need to know about the risk factors, signs, tests to diagnose, and treatment of newly diagnosed and recurrent ALL in this expert-reviewed summary.
red blood cells0.416225
cancer treatment0.28631
chemotherapy0.431874
treatments0.247489
PDQ cancer information0.278302
clinical trial search0.311111
white blood cells0.50903
children0.34365
systemic chemotherapy0.367092
higher doses0.258659
mature blood cells0.277223
Natural killer cells0.232346
cancer information summary0.242631
clinical trial0.414978
stem cells0.325781
stem cell transplant0.490178
Lymphoblastic Leukemia Treatment0.242048
blood cells0.556083
intrathecal chemotherapy0.289545
radiation therapy0.442509
General information0.218828
child0.225345
treatment0.73359
immature blood cells0.228445
NCI-supported cancer0.228604
cancer cells0.364563
remission induction0.378898
anticancer drugs0.454791
specific cancer cells0.244448
acute lymphocytic leukemia0.228943
certain changes0.25566
treatment clinical trials0.245143
blood stem cells0.262182
National Cancer Institute0.245665
spinal cord0.639894
) cells.0.915202
new treatment0.267478
consolidation /intensification0.293759
childhood0.307766
clinical trials0.932686
combination chemotherapy0.358378
maintenance phases0.246634
brain0.275475
bone marrow0.619374
Philadelphia chromosome0.248781
cancer clinical trials0.319159
acute lymphoblastic leukemia0.930995
cancer0.710977
information0.309067
CLICK HERE
1666 National Cancer Institute Html en Testicular Cancer Screening (PDQ®)–Patient Version Expert-reviewed information summary about tests used to detect or screen for testicular cancer.
testicular self-exams0.545422
ongoing clinical trials0.499986
PDQ cancer information0.758311
testicular cancer0.955987
testicular germ cell0.59857
testicular carcinoma0.546926
NCI Web site0.507088
testicular cancers0.553122
clinical trials0.669739
early detection0.495849
germ cells0.505641
cancer information summary0.64569
clinical trial0.511819
breast cancer prevention0.524202
spermatic cord0.49407
PDQ summaries0.534816
cancer patients0.49191
latest published information0.509374
NCI’s PDQ0.538459
cancer symptoms0.51215
NCI PDQ cancer0.620022
tests0.527688
testicular cancer screening0.701295
routine screening test0.519043
PDQ Screening0.553678
testicles0.486139
screening tests0.48752
Cancer Information Service0.545478
common cancer0.501504
male sex glands0.496865
Prevention Editorial Board0.56412
treatment clinical trials0.501604
National Cancer Institute0.653794
PDQ documents0.525451
cancer doctors0.485997
long coiled tube0.493438
new treatment0.506259
health professional version0.485461
Cancer screening trials0.571582
PDQ database0.532773
Cancer Care page0.527585
Testicular Cancer Treatment0.685082
risk factor0.499445
PDQ summary0.654344
routine physical exam0.576949
cancer information summaries0.554625
health professional versions0.489301
comprehensive cancer information0.555761
CLICK HERE
1716 National Cancer Institute Html en Human Papillomavirus (HPV) Vaccines A fact sheet about human papillomavirus (HPV) vaccines for the prevention of infection with certain types of HPV, which is the major cause of cervical cancer.
transmitted HPV types0.372301
HPV prophylactic vaccines0.352103
anal HPV0.291899
HPV transmission0.315597
available HPV vaccine0.365066
HPV types0.787213
Disease Control0.208664
HPV vaccination coverage0.329587
HPV vaccination program0.333099
bivalent HPV vaccination0.335395
hpv vaccination0.566558
cervical cancer0.335142
high-risk HPV infections0.38085
HPV surface components0.326712
genital HPV infection0.36709
available HPV vaccines0.389305
persistent HPV0.314117
high-risk hpv types0.523029
HPV vaccines0.696012
human papillomavirus0.38319
HPV vaccination series0.361602
HPV infections0.517426
genital HPV infections0.379278
contact.  HPV infections0.352636
human papillomavirus vaccine0.256852
hpv infection0.466234
current HPV vaccines0.379891
women0.226009
United States0.375279
Updated HPV Vaccination0.330423
current HPV infections0.328908
therapeutic HPV vaccines0.356162
human papillomavirus vaccines0.212379
HPV Vaccination Recommendations0.367966
Yes. Because HPV0.297056
dozen high-risk HPV0.362742
HPV0.924148
routine HPV vaccination0.357555
genital warts0.26905
quadrivalent HPV vaccine0.329163
additional HPV types0.3896
quadrivalent human papillomavirus0.21339
HPV vaccine product0.372857
additional high-risk HPV0.343778
currently approved HPV0.315107
high-risk HPV type0.392493
Gardasil0.309437
vaccine-targeted HPV types0.33361
et al0.409031
CLICK HERE
1858 National Cancer Institute Html es Tratamiento del cáncer de glándulas salivales (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento del cáncer de glándulas salivales.
salivary gland carcinoma0.756611
salivary neoplasms0.424559
estroma linfoide0.413137
prognostic factors0.41902
gland tumours0.43032
Spiro RH0.465562
Sin embargo0.429856
advanced salivary0.421758
Malignant parotid tumors0.41189
minor salivary0.423431
tumores benignos0.597781
Salivary Gland Disease0.423228
tumores malignos mixtos0.484605
botulinum toxin0.428989
Radiat Oncol Biol0.471433
glándulas salivales benignos0.570833
neck neoplasia following0.437258
fuerte predilección0.414088
Parotid gland tumours0.420714
salivary gland0.859636
Head Neck Surg0.476609
mucoepidermoid carcinoma0.597885
gland malignant neoplasms0.445484
tumores benignos mixtos0.438326
único síntoma0.425265
parotid gland0.431427
lesiones carcinoma0.466113
relativa frecuencia0.450675
sección carcinoma0.486375
carcinoma ex-tumor0.470245
unresectable carcinomas0.426636
Oral Oncol0.420027
major salivary glands0.414421
Otolaryngol Head Neck0.413034
término carcinoma0.475993
carcinoma epidermoide0.472012
edad promedio0.670934
Salivary Gland Tumours0.424182
carcinoma with0.481329
adenocarcinoma sai0.463524
carcinoma salival basaloide0.481935
carcinomas quísticos adenoides0.459095
Botulinum toxin treatment0.413697
with parotid carcinoma0.483397
Oncol Biol Phys0.47266
linfadenoma sebáceo0.417003
elemento carcinoma0.475416
carcinoma mucoepidermoide0.988653
neoplasias benignas0.45166
CLICK HERE
4300 National Cancer Institute Html en Cancer Moonshot℠ Blue Ribbon Panel The Blue Ribbon Panel Report outlines 10 recommendations to accelerate progress against cancer. The panel was established to ensure that the Cancer Moonshot's approaches are grounded in the best science.
BRP0.544911
National Cancer Advisory0.917882
pediatric cancer0.537601
relevant scientific sectors0.512578
Reduce cancer risk0.54942
dynamic 3D maps0.479491
early detection0.494934
therapeutic targets0.493364
presidentially appointed National0.528792
new preclinical models0.493659
national cancer data0.584851
previously effective treatments0.485016
early detection strategies0.482919
new therapeutic targets0.480719
cancer resistance0.471789
E. Intensify research0.49241
translational science network0.495254
cancer technologies0.513048
public idea submission0.473834
broader cancer community0.579774
transformative research recommendations0.554836
cancer immunotherapy network0.593107
Ribbon Panel report0.661804
tumor evolution0.579883
cancer health disparities0.557334
final recommendations0.465114
Cancer Immunology0.464811
human tumor evolution0.504864
specific recommendations0.466439
cancer prevention0.548373
C. Develop ways0.499508
tumor profile data0.530939
cancer cells0.472187
group members0.429792
Minimize cancer treatment0.561924
direct patient involvement0.494413
joint recommendations0.465939
3D cancer atlas0.546232
multiple groups0.44011
Cancer Moonshot Task0.60025
Blue Ribbon Panel0.890429
groups0.493987
BRP members0.537843
major topic areas0.508582
Cancer Advisory Board0.925259
efficient data analysis0.49446
Develop new cancer0.562862
future patient outcomes0.484191
CLICK HERE
15882 National Cancer Institute Html es Cardo mariano (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos sobre el uso del cardo mariano como tratamiento para personas con cáncer.
Silybum marianum0.735385
Agarwal R0.945743
cell lines0.375003
cell growth0.494513
prostate carcinoma du1450.373715
DNA synthesis0.442196
carcinoma cell0.46955
silybum marianum l0.361146
Inhibitory effect0.390679
Agarwal C0.386743
receptor modulator activity0.356592
Mol Carcinog0.378538
Cancer Res0.59348
carcinoma cell growth0.407562
prostate carcinoma cells0.4865
Singh RP0.367955
flavonoid antioxidant0.678831
active constituent0.382485
Antiproliferative effect0.363827
lipid peroxidation0.585387
Biochem Pharmacol0.461277
chemopreventive effects0.369648
cardo lechero0.365629
patients with0.374862
cell growth inhibition0.393232
Sonnenbichler J0.428511
prostate carcinoma0.590474
Campos R0.414926
Pharmacol Res0.429959
protective effects0.379153
Biophys Res Commun0.50103
prostate-specific antigen with0.369145
carcinoma du145 cells0.397873
Biochem Biophys Res0.508991
Silymarin effects0.38621
Biomed Res Int0.385769
Clin Biol Res0.375557
insulin-like growth factor-binding0.358425
stimulatory effects0.357205
Zhao J0.53049
Guerra R0.490633
with cell growth0.41107
comparison with0.378495
silibinin inhibits0.378656
Planta Med0.529049
protects against0.371646
Mutat Res0.369799
from silybum marianum0.396284
Res Commun0.505421
CLICK HERE
16049 National Cancer Institute Html en Managing Costs and Medical Information People with cancer may face major financial challenges and need help dealing with the high costs of care. Cancer treatment can be very expensive, even when you have insurance. Learn ways to manage medical information, paperwork, bills, and other records.
cancer treatment0.452926
file folder0.451204
emergency room0.448618
medical bills0.53618
state specific information0.467913
insurance coverage0.460494
health care team0.51276
American Cancer Society0.460319
payment options0.46621
non-medical phone calls0.432178
social worker0.59281
clinical trials0.467219
health care providers0.479775
State Health Insurance0.507522
cancer care0.486022
research costs0.450096
Track daily events0.441284
Insurance Assistance Service0.484543
health care costs0.531061
patient care costs0.553498
travel costs0.463012
government health insurance0.504906
treatment0.485685
electronic medical record0.447232
health care bills0.536309
insurance company pay0.509196
help finding referrals0.489042
Cancer Information Service0.588627
financial issues0.432149
Health Insurance Assistance0.617568
special email account0.433974
sample chart0.453844
discount drug programs0.446076
separate folder0.500544
extra costs0.480459
bills0.574419
hospital0.455427
health care0.679621
key medical information0.460671
insurance company0.914855
costs0.714673
NCI Cancer Information0.458766
important medical information0.475214
human resources department0.455264
medicine0.454681
health care coverage0.489272
insurance companies0.472181
doctor0.602384
mobile device0.452113
CLICK HERE
17193 National Cancer Institute Html en U.S. - China Program for Biomedical Research Cooperation U.S. - China Program for Biomedical Research Cooperation Preliminary Program Review.
Office0.440565
OAR0.472714
Allergy0.446266
scientific accomplishments0.62865
projects0.51324
Additional outcomes0.632018
National Natural Science0.9169
Mental Health0.663295
Chinese scientists0.664312
translational biomedical research.0.976759
National Cancer Institute0.919012
Foundation0.442112
preliminary evaluation0.675445
US-China0.436834
results0.435543
National Institute0.932171
National Institutes0.697264
common successes0.636736
Administrative Supplements0.654736
Stroke0.440417
Collaborative Biomedical Research0.935063
Global Health0.637782
NSFC0.441999
future collaborative programs0.854353
impacts0.442029
countries0.439905
NIAID0.482086
NIH0.458074
international collaboration0.640713
joint initiative0.663479
Neurological Disorders0.660677
NIMH0.468305
Researchers0.441544
U.S.-China Program0.677605
report0.435896
Infectious Diseases0.665033
scientifically meritorious investigations0.921915
Biomedical Research Cooperation0.865108
Preliminary Program Review0.859879
AIDS Research0.660227
R01 mechanisms0.711872
CLICK HERE
17294 National Cancer Institute Html es Anemia Información y consejos para controlar la anemia, un efecto secundario del tratamiento del cáncer.
suficientes glóbulos0.941582
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.